224 filings
Page 5 of 12
8-K
eedzm8l
30 Sep 20
Collegium Announces Settlement with Teva Resolving Xtampza® ER Patent Litigation
8:00am
8-K
v33ki56972y5
25 Sep 20
Collegium Appoints Rita Balice-Gordon to its Board of Directors
4:03pm
S-8
0tlyem88bqftm
13 Aug 20
Registration of securities for employees
4:06pm
8-K
1xv72
5 Aug 20
Collegium Reports Net Income of $8.1 Million in the Second Quarter of 2020
4:01pm
8-K
ejhhpumwe1i0rl
9 Jul 20
Departure of Directors or Certain Officers
5:00pm
8-K
64pognmjda
22 May 20
Submission of Matters to a Vote of Security Holders
4:08pm
8-K
bkis1zor d3wd7
7 May 20
Collegium Reports First Quarter 2020 Profitability
4:01pm
DEFA14A
gop85732x
9 Apr 20
Additional proxy soliciting materials
4:09pm
EFFECT
qpcjtwe bluv
31 Mar 20
Notice of effectiveness
12:15am
CORRESP
k0eoqzrd5 79z1n0m
27 Mar 20
Correspondence with SEC
12:00am
PRE 14A
vtcai7qs
25 Mar 20
Preliminary proxy
4:01pm
UPLOAD
etbgr2swujkbo i34ib
23 Mar 20
Letter from SEC
12:00am
8-K
zb6oysb08j0pp80zu6
27 Feb 20
Collegium Reports Full-Year 2019 Revenue of $296.7 Million
4:01pm
8-K
ptzf t8ifdw
13 Feb 20
Collegium Announces Closing of the Nucynta Franchise Acquisition
5:10pm
424B5
sns6r5d69 l3
11 Feb 20
Prospectus supplement for primary offering
4:08pm